Susan Swetter, M.D.

Clinical Focus

• Cancer> Cutaneous (Dermatologic) Oncology
• Basal / Squamous Cell Carcinomas
• Basal / Squamous Cell Carcinomas - Dermatology
• Cutaneous Oncology
• Dermatology

Administrative Appointments

• President, Board of Directors, American Cancer Society, Santa Clara County Unit (2009 - 2011)
• Member, Melanoma Panel, National Comprehensive Cancer Network (2007 - 2013)
• Member, Board of Directors, American Cancer Society, Santa Clara County Unit (2007 - 2012)
• Member, Melanoma Clinical Guidelines Task Force, American Academy of Dermatology (2006 - 2012)
• Member, Scientific Programs Committee, Melanoma Section, American Society of Clinical Oncology (2006 - 2008)

Honors and Awards

• Humanitarian Award Recipient, Melanoma Research Foundation (2012)
• Member, American Dermatological Association (2011)
• Leadership Award, Melanoma Care Coalition (2007)
• President’s Volunteer Service Award, President’s Council on Service & Civic Participation, Corporation for National & Community Service (2007)
• Recognition for Excellence in Teaching, Stanford University School of Medicine (2004, 2009)

Professional Education

Graduate & Fellowship Program Affiliations

• Dermatology

Community and International Work

• President, Board of Directors, American Cancer Society Santa Clara County Unit, Campbell, CA 
• Program Director, Stanford Skin Cancer Screening Program, 1995-2011, Stanford Medicine Outpatient Clinics 

Internet Links

• Stanford Cancer Center - Melanoma Program

Current Research Interests

Dr. Swetter has directed the Pigmented Lesion and Melanoma Programs at Stanford University Medical Center and Cancer Center and VA Palo Alto since 1995. She serves as the national dermatology liaison to the Eastern Cooperative Oncology Group (ECOG) Melanoma Committee and Co-Chairs the Melanoma Prevention Working Group, a national forum for research collaboration among academic oncologists, dermatologists, epidemiologists, and surgeons dedicated to cancer control and prevention, and currently comprised of 29 Intergroup (ECOG, SWOG, CALGB) melanoma centers in the US. Dr. Swetter's research interests include secondary prevention of melanoma, including early detection and screening of high-risk groups, melanoma chemoprevention in individuals with atypical mole syndrome, and research focused on increasing professional and public education to improve melanoma awareness. She is also engaged in clinical studies of the epidemiology, prognostic factors, and therapy of melanoma and nonmelanoma skin cancers.

Clinical Trials

• Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Solar Melanoma That Cannot Be Removed By Surgery Recruiting
• Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery Recruiting
• Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy Recruiting
• Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma No longer recruiting
• A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma No longer recruiting

Publications

• Attitudes toward indoor tanning among users of sunless tanning products. Mahoney A, Swetter SM, Biello KB, Resnick EA, Feuerstein I, Geller AC. Arch Dermatol. 2012; 148 (1): 124-6
• Gender Disparities in Patients With Melanoma: Breaking the Glass Ceiling. Sondak VK, Swetter SM, Berwick MA. J Clin Oncol. 2012
• Melanoma. Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, Dimaio D, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Lind A, Martini MC, Olszanski AJ, Pruitt SK, Ross MI, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM. J Natl Compr Canc Netw. 2012; 10 (3): 366-400
• Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: Evaluation of potential chemopreventive activity. Curiel-Lewandrowski C, Swetter SM, Einspahr JG, Hsu CH, Nagle R, Sagerman P, Tangrea J, Parnes H, Alberts DS, Chow HH. Cancer. 2012
• Reporting and registering nonmelanoma skin cancers: a compelling public health need. Geller AC, Swetter SM. Br J Dermatol. 2012; 166 (5): 913-5